Main features

  • At least one-month room temperature stability
  • Improved sensitivity of proprietary RdRP and E assays together with RNase P assay as an internal control
  • SARS-CoV-2 full genomic RNA spiked with human RNA used as a positive control
  • 100% clinical accuracy
  • 100% analytical sensitivity with 2 RNA copies/rxn
  • 100% specific for SARS-CoV-2
  • Validated on real clinical samples
  • No cold chain shipping needed



The rTEST COVID-19 qPCR kit is an innovative, improved, re-designed and proprietary version of the WHO-recommended Charité, Berlin protocol. The kit contains three sets of primers and TaqMan® probes targeting the SARS-CoV-2 specific E and RdRP genes and human RNase P. For E and RdRP genes, we developed dual TaqMan® probes to increase the sensitivity and specificity of our 1-Step RT-qPCR method. The 5X One-step Probe CoV Mix (ROX) reagent from Solis BioDyne includes ROX passive reference dye with a unique molecular structure allowing our RT-qPCR method to be compatible with all ROX-dependent and ROX-independent real-time PCR cyclers.

A single kit is sufficient for 400 testing reactions and also offers flexibility in testing by permitting either single gene screening or precision dual gene diagnostics. E or RdRP gene (based on the end-user preference) can be exclusively used for 400 screening tests. This option is recommended when many symptomatic patients have to be screened at once. The precision dual gene option is based on running 200 screening assays first (E or RdRP gene) followed by 200 confirmation assays to confirm positive screening results (E or RdRP gene) or eliminate false-positive results. In addition, conducting an internal control assay for human RNase P assesses appropriate swab collection and RNA extraction, while eliminating false-negative results. Thus, for the precision dual gene diagnostics workflow, two testing reactions should be performed per one patient and this option is recommended when precision testing is essential.

For more info see User Information

Registration code: P1430A

MultiplexDX, s.r.o.
IČO: 50111965
Ilkovičova 8, 841 04 Bratislava, Slovenská republika
+421 2 902 68 310

© 2020 MultiplexDX, s. r.o. All rights reserved.
rTest COVID-19 is a trademark of MultiplexDX, Ltd.
All other product names and trademarks are the property of their respective owners


rTest COVID-19 qPCR kit

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
+421 290 268 308



Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

Products & Services

COVID-19 Diagnostics

The diagnostic kits vDetect and rTest are based on an improved and re-designed Charité Berlin protocol also recommended by the WHO.

Custom Oligonucleotides

We offer custom, high quality synthesis of aptamers, siRNA, miRNA, antagomirs, qPCR probes, oligonucleotide triphosphates etc.

RNA Sequencing

MDX small RNA sequencing products are compatible with Illumina sequencing technology and designed for the simplest, the most economical, the most precise and automated small RNA library preparation, enabling a great elimination of sequencing errors and biases.

Personalized Diagnostics

MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining our proprietary visual and sequencing technologies into one diagnostic test.


MultiplexDX offers a wide range of bioinformatics services, including genome assembly, gene expression, metagenomics analyses and data visualization.